ELAHERE Trademark

Trademark Overview

On Friday, January 18, 2019, a trademark application was filed for ELAHERE with the United States Patent and Trademark Office. The USPTO has given the ELAHERE trademark a serial number of 88268164. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 15, 2022. This trademark is owned by ImmunoGen, Inc.. The ELAHERE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions
elahere

General Information

Serial Number88268164
Word MarkELAHERE
Filing DateFriday, January 18, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 15, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements

Goods and ServicesPharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunoGen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameImmunoGen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Monday, August 15, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 15, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 5 GRANTED
Wednesday, January 5, 2022SOU EXTENSION 5 FILED
Thursday, January 13, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, January 5, 2022TEAS EXTENSION RECEIVED
Tuesday, June 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 11, 2021SOU EXTENSION 4 GRANTED
Friday, June 11, 2021SOU EXTENSION 4 FILED
Friday, June 11, 2021TEAS EXTENSION RECEIVED
Wednesday, December 16, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 14, 2020SOU EXTENSION 3 GRANTED
Monday, December 14, 2020SOU EXTENSION 3 FILED
Monday, December 14, 2020TEAS EXTENSION RECEIVED
Saturday, June 20, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 18, 2020SOU EXTENSION 2 GRANTED
Thursday, June 18, 2020SOU EXTENSION 2 FILED
Thursday, June 18, 2020TEAS EXTENSION RECEIVED
Saturday, January 4, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 2, 2020SOU EXTENSION 1 GRANTED
Thursday, January 2, 2020SOU EXTENSION 1 FILED
Thursday, January 2, 2020TEAS EXTENSION RECEIVED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, March 30, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 30, 2019ASSIGNED TO EXAMINER
Monday, February 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 22, 2019NEW APPLICATION ENTERED

Related Keywords

elahere preparations pharmaceuticals pharmaceutical treatment namely human disorders conditions oncological cancer